Yossi Maimon
2015 - Protalix BioTherapeutics
In 2015, Yossi Maimon earned a total compensation of $780.5K as Vice President, Chief Financial Officer at Protalix BioTherapeutics, a 9% decrease compared to previous year.
Compensation breakdown
| Bonus | $246,009 |
|---|---|
| Option Awards | $102,215 |
| Salary | $266,776 |
| Stock Awards | $97,120 |
| Other | $68,398 |
| Total | $780,518 |
Maimon received $266.8K in salary, accounting for 34% of the total pay in 2015.
Maimon also received $246K in bonus, $102.2K in option awards, $97.1K in stock awards and $68.4K in other compensation.
Rankings
In 2015, Yossi Maimon's compensation ranked 9,093rd out of 13,638 executives tracked by ExecPay. In other words, Maimon earned more than 33.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,093 out of 13,638 | 33rd |
Division Manufacturing | 3,464 out of 5,187 | 33rd |
Major group Chemicals And Allied Products | 1,267 out of 1,857 | 32nd |
Industry group Drugs | 1,032 out of 1,531 | 33rd |
Industry Biological Products, Except Diagnostic Substances | 185 out of 260 | 29th |
Source: SEC filing on March 16, 2017.
Maimon's colleagues
We found four more compensation records of executives who worked with Yossi Maimon at Protalix BioTherapeutics in 2015.
2015
Moshe Manor
Protalix BioTherapeutics
Chief Executive Officer
2015
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2015
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Product Development
2015
Tzvi Palash
Protalix BioTherapeutics